Overview Bendamustine and Bevacizumab for Advanced Cancers Status: Completed Trial end date: 2014-05-01 Target enrollment: Participant gender: Summary The goal of this clinical research study is to find the highest tolerable combination dose of bendamustine and bevacizumab that can be given to patients with advanced cancer. The safety of the drug combination will also be studied. Phase: Phase 1 Details Lead Sponsor: M.D. Anderson Cancer CenterCollaborators: CephalonNational Comprehensive Cancer NetworkTreatments: Bendamustine HydrochlorideBevacizumab